Hello folks! So in this video, we're going to be talking about the top six penny stocks that are going to be spiking in February 2020. But why can I say this? Well, because the companies on these lists literally tell you the exact date at which price action changing events are going to be occurring such as with FDA approvals, phase data releases, presentations, and insider activity. But what is actually the best way to play these? well to find out? the best way is to look back at last month's picks and see what the best strategies were. ITC I Was our first pick in the video.

They got approved for their drug for Schizophrenia which resulted in their stock price running up a casual 194 percent. but to be honest, these 194 % runners aren't that common. It's usually like 30 to 40% but nonetheless, this was our first pick and it was on a FDA approval. Now D Our Rx was our second pick.

We announced it when it was at $2 and 40 ish. It had an anticipatory run-up, then a beat-down on negative news, but since every reaction is an overreaction, we had a sizable correction afterwards. Another pick we announced was Epgm. Now this was also something that was relevant in the last few weeks, but we announced Dpcm had originally $20 in 74 cents.

It had a pre anticipatory run-up pre factored in good news and then got beat down and had a partial correction. When the good news came out because it had already pre factored it in. another pick was very. We announced it at 288.

it ran up to 474 before getting beat down after the announcement. again pre factoring in. and for beginners these charts they may look super easy. All you have to do is follow the catalysts.

But the truth is that knowing a stock is about to spike isn't the same thing as being able to profit off the Spike You see your entry point and exit point game, or of utmost necessity because we never know for certain whether or not the news is going to be positive or negative. That means there's only two ways to actually play these stocks. The first is in the case of a pre anticipatory run-up playing off price breaks running up to the announcement. The second is playing off the reaction.

What happens after the announcement, but holding through announcement is almost always a gamble. In fact, even if you hold through an announcement and the announcement is positive, your stock price may still get beat down if it pre factored it in ahead of time. But the way that you can make this a win-win is by playing off the before and the after instead of gambling in between. And this is great because if it doesn't make sense to be in a position at any point, you could just not take the position, whereas if you gamble through, then you're just holding randomly and hoping.

A lot of folks think that a good pick means that you could just randomly buy in at any point, in and randomly sell out at any point. But that is not the truth. You need to have a concrete trading plan. But anyways, folks, you know that a lot of work goes into creating these videos for you.

I Put a lot of research into finding all the different opportunities and the only thing that I ask in return is that you hit that ravishing like button and quick plug for folks who are wondering what broker to trade these stocks on. I Always like to send new traders over to Weeble People has an excellent platform with tons of great features to get you started trading within the stock market. It's a pretty intuitive platform and I found that most people who I've signed up have really enjoyed it. and if you do sign up with our link below, you will get not one but two free stocks when you sign up and deposit any amount.

and the second free stock can be valued up to $1400 so it's a pretty good deal for trying out a free broker. Okay, first a Grx now a TRX We'll be having their FDA approval decision for Twala which is their contraceptive patch on February 16th. Now this has gone through quite a process of delay and is now widely expected to reach a positive conclusion. But folks I really couldn't give less of a hoot about whether an office gets approved.

We just need other people to think that it's going to get approved so that we have our pre anticipatory run-up and we are quite lucky to be in a stage that we are starting to see some selling off. I'd love to see more in order to make way more upward potential for us. We want to have a good deal and that is important as even our monkey analyst friends are giving it a price target at 450. Now that's not a lot of wiggle room and our monkey analyst friends there are always blowing targets out of proportion.

So if you consider that we don't have that much upside to the monkey level of support, that's not swell because all of a sudden you have all of the sheep investors saying hey, the monkeys think that this is overhyped. But anyways, we are seeing this selling off and I'd love to see more selling off leading up to the state so that we can play off the upward potential. But in terms of Ag our X's previous price action though, we have established previous spike ability to knits here here here and Heather now spike ability is important because if something has a previous pattern of spiking on previous news, then it's more likely that it's going to spike on future needs as well. Pretty intuitive, but the spike ability with Ag Rx is a little bit more attractive because it's more spread out than with most biotech opportunities.

A lot of biotech opportunities they run up like inflamed banshees and then all of a sudden they burn. The banshee burns and that dies. It's horrible. But with Ag Rx, the write-ups are a little bit more spread out.

It runs up a little bit slower, which is great because that means we have more ability to ride sustainable price strength. But besides that, what we are looking for is some more pushing back and then some clean running not prior to approval and again since it is expected to be approved. It's likely that AG Rx will have some strong factoring in of share price, which could then add some fire to any anticipatory run-up. And how do you actually play price strengths well simply by monitoring for strong elevated factors and buying in at conformation? I Have a lot of folks that I work with both in zip trader circle and in my premium corset trader you where people are like hey, Charlie I hate following these rules.

The rules never change, they're always the same. It's so boring. but folks, this is a repetitive business. If you have a winning strategy, don't go and throw it to the Gators work on honing in on that strategy.

And sometimes that means repeating. A lot of money is made in the mundane. so if you're doing something and it's mundane, but it's working, keep doing it. Oh Charlie that's so boring I Want to have fun I Want to be a fun trader? Well, is losing money fun to you because if it is then perfect, they'll have fun gamble on random stock tickers.

But folks, on a serious note, in this business, you need to have rules and you need to stick to your rules trough Now Traub Will be having their phase 2 data presented February 13th. But why do we like phase data presentations? Well, because they bring heightened interest into what a company is doing and if done properly, adds enough hype to run up the share price and even better be down the share price so that we can buy in at over reaction lows. But this is the company's opportunity to bolster their share price by convincing folks that what they are doing is the best thing since shredded bread. And the main way to qualify whether or not a stock is susceptible to news reactions is by looking at previous spike ability and trove is extremely reactive with seven to eight notable spikes in the last 180 days.

Now that we've declared spike ability, we know that buying into price strength upon future news spike ability is a winning strategy. but we also know that holding through validation is a losing strategy. Look, what happened after all these spikes? Oh, they got beat down because every reaction is an overreaction. So when you enter a position, you need to have a concrete entry and a concrete exit point.

One more thing that I do want to mention about Trot is we aren't as prone to pre anticipatory run ups with the setup since this is a presentation instead of an actual approval or phase data release. that means that the focus should be spent more on plain Prai strength on the day of the presentation instead of just waiting until afterwards. Presentations are great because they usually don't result in shareholding, but also can spike investor interest with many if not most of our FDA approvals in Phase data releases. The SEC tends to the whole Tashera's and this can make it a little bit more complicated if you're not paying attention, but with presentations, that's usually not the case so playing these types of opportunities can be a lot more fun.

Be Xrx, we'll be having their FDA approval date on February 20th for their treatment for acute pain for surgical patients. Now with Pxrx, this is fairly low volume. We need to see upward volume sentiment in order to be convinced to take a position. A lot of folks love to say Charlie volume is a scam.

All you need to do is look at the price action, but these are mostly newbies because the problem is folks that if you don't look at the volume, you first of all won't know whether or not you have enough liquidity to even trade the setup that you're trying to trade, but you also won't know that you have heightened investor interest or upward sentiment. Now a lot of people that say volume is a scam and stuff like that they usually trade really large cap stocks, so they don't really care that much about volume because they know they always have the liquidity. But when you're trading biotech stocks, you need to have the liquidity and you need to track liquidity to see we're not. The upward sentiment is: if there's no upper sentiment, then you're like, okay, well, that's a deprecating factor, but one of the reasons that I've included Bxr X on this list is because we have strong institutional backing.

Now, this is a play that boasts the backing of both Blackrock and Vanguard. And for those of you who are unfamiliar whenever we see Blackrock holding, it's sort of a sign that the fundamentals within the company that were trading aren't complete trash. This is quite important because when you get into the lower cap variety all of a sudden you're in this area. We're The fundamentals could lead you to buying a ticking time-bomb but when you have large institutional backing, you're less likely to have that taking time bomb.

But notice that I said less likely instead of not likely. A lot of these low cap stocks are very volatile, so you need to make sure that you're getting in, your getting your diet Coke and then you're getting out now. KD and M will be having their presentation on the 23rd. As a recap, they had positive phase Two data on November 11th, which is what caused the spike here.

Now, the monkeys are predicting long-term upside to $13.25 which is, of course, a hundred and ninety percent of upside. Now folks, these analysts, They think we're stupid. They think you and I that were idiots. They love to overhype nearly every stock.

And then when the sheep buy in, they get slaughtered. and then the analysts are like, oh, I'm sorry sheep Here are some more price targets for you to waste your money on. No folks, these analysts are not out for your best interest. A lot of people love to think they are these days.

Quite frankly, it's very difficult to find a reasonable analysts ranking, but that is fine. Let's use the analysts to our advantage and let the Sheep buy in, bolstering our elevating factors. So with KD and M I want to emphasize buying into an upward direction? Remember when we are above the red directional SMA line? That means that we are in an upward direction and when we are below your n a downward direction? Pretty simple stuff. That's we do want elevating factors.

It will make sense to get in upon an upward direction. but you need to balance your other factors right. If you're trying to find an entry point and you just got in when it's oversold and increasing. hey, you just got in when it's both discounted and showing signs of recovering.

So that's another elevating factor. Important stuff to note: Okay, CL RP will be having their phase one and two data updates for the drugs for lymphoma and myeloma on the 19th. but I Want to emphasize that with CL RB It's only a stock that you can really play if you have heightened volume and height and volume comes around cattle estates, but its volume right now is way too low to make it a safe trade at this point. But when FDA announcements come out CL RB and others can have heightened volume due to Catalyst bringing in investor interests as we see based on the previous price action.

But in terms of actual price action, we've established previous bikeability and have broken into a solvent upper direction. But we need better volume, better volume folks. By the way, if you're freaking out on how to follow up with these opportunities and how keep track of them well, you can simply join our free Zip Trader Circle Facebook Group within the Zip Trader Circle Facebook Group I post nightly watch lists and we have all these different tickers and different opportunities that we see is valuable each and every single night. You can join that by clicking the link in the description below.

Now each HOD actually has a March 17th approval date. However, I Want to make sure to include this in this video so that folks can be on the lookout for early, pre anticipatory running up. Now each one has a previous pattern of running up before news. It also has previous spike ability.

So in terms of what I'm actually looking for with an opportunity like this is just heightened volume in price strength moving through. February One of the things that I personally have a major focus on and you don't have to focus on this, but it's something that I found to be really helpful is that when it comes to trading any type of setup, make sure that you have priced ranks and you have that clean running up because that way you can just write the price break from confirmation to validation and you can measure whether or not you're in a weak position or not. if I go in and seen how much real estate is between the SMA line and the actual price action and the more real estate the better. In order to find that you do need to be able to identify elevating factors such as an upcoming catalyst being oversold, so on and so forth.

There's tons of other elevating factors and if you go throughout this channel or you look on zip trader you you can find our total breakdown of different elevating factors. Okay folks, well I do hope that this video was valuable for you. I Do want to remind you know when it comes to trading penny stocks, you need to make sure that you have enough volume and you need to make sure that you have a clear catalyst. Don't just buy penny stocks because they're cheap.

That's not the way to go. You'd be better off buying something of a higher cap variety if that's your strategy when it comes to you Biotech plays. You need to buy in upon price strength and understanding what it is that's actually going to drive the price. Is that a catalyst? Do We have an FDA approval? What is it? And make sure to identify that and have a trading plan that's going to allow you a clear entry point for buying in and a clear exit point for selling out.

And you need to be prepared to be wrong. Don't always assume that you're going to be correct. if you're wrong, you need to sell out at validation. And if you're right, you also sell out at validation.

But the thing is that when you write, the validation point is at a profitable location anyways. If you have any questions, feel free to reach out to me Any comments section below or join our free Facebook group. For folks who would like extra guidance in growing their account, we do offers a traitor view which is our premium course and group that I work with each and every single day. Anyways, folks have a great day and I'll see you in the next video.